Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K182904

    Validate with FDA (Live)

    Date Cleared
    2019-07-05

    (262 days)

    Product Code
    Regulation Number
    892.2050
    Age Range
    All
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    syngo.MR Applications is a syngo based post-acquisition image processing software for viewing, manipulating, evaluating, and analyzing MR, MR-PET, CT, PET, CT-PET images and MR spectra.

    Device Description

    The syngo.MR Applications are syngo based post-processing software/applications to be used for viewing and evaluating ' MR images provided by a maqnetic resonance diagnostic device and enabling structured evaluation of MR images. syngo.MR Brain Morphometry extends the MR Neurology workflow and offers a comprehensive package for the automatic calculation of the volume properties of different brain structures using MPRAGE datasets, which are typically acquired for a typical MR examination of the head.

    With this premarket submission, the new functionality syngo.MR Brain Morphometry is introduced to extend the MR Neurology workflow that is a part of the formerly cleared medical device syngo.MR Applications (K180336).

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for syngo.MR Brain Morphometry, based on the provided text:

    Acceptance Criteria and Reported Device Performance

    The document states that "Acceptance criteria for performance tests were defined based on a literature review. In all validation experiments, syngo.MR Brain Morphometry passed the acceptance criteria." However, it does not explicitly list the specific numerical acceptance criteria. Instead, it provides the reported device performance in terms of correlation coefficients.

    Performance MetricAcceptance Criteria (from literature review)Reported Device Performance
    AccuracyNot explicitly stated (passed literature-based criteria)Correlation with reference device: 0.95 (grey matter), 0.80 (hippocampus), 0.92 (white matter)
    RepeatabilityNot explicitly stated (passed literature-based criteria)Volume correlation: 0.96 (grey matter, hippocampus, white matter), 0.99 (ventricular system)
    ReproducibilityNot explicitly stated (passed literature-based criteria)Volume correlation: 0.97 (grey matter), 0.94 (hippocampus), 0.98 (white matter)

    Study Details

    1. Sample Size Used for the Test Set and Data Provenance:

      • Test Set Sample Size: 1200 subjects.
      • Data Provenance: The dataset consisted of Alzheimer's patients (AD), mild cognitive impaired patients (MCI), and healthy controls (HC). The country of origin and whether the data was retrospective or prospective are not specified in the provided text.
    2. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:

      • The document primarily describes a validation study comparing the automated results to a "reference." It does not explicitly state that human experts were used to establish a ground truth for the test set in the traditional sense of consensus reading for image interpretation. The "reference" appears to be an established method or device, but details on its nature (e.g., manual segmentation by neuro-radiologists) are not provided.
    3. Adjudication Method:

      • Not applicable/Not described. The validation appears to be against a "reference" rather than through an adjudication process among human readers.
    4. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

      • No, a MRMC comparative effectiveness study was not explicitly conducted or described. The study focused on the standalone performance of the algorithm against a reference.
    5. Standalone Performance:

      • Yes, a standalone (algorithm only) performance evaluation was conducted. The performance metrics (accuracy, repeatability, reproducibility) were quantified for syngo.MR Brain Morphometry.
    6. Type of Ground Truth Used:

      • The accuracy of volumetric results was validated by comparing the automated results to a "reference." The specific nature of this reference (e.g., manual segmentation, results from another validated software, pathology) is not detailed.
    7. Sample Size for the Training Set:

      • The sample size for the training set is not provided in the document. The text focuses on the validation of the new feature.
    8. How the Ground Truth for the Training Set Was Established:

      • This information is not provided in the document.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1